Skip to main content
. 2018 Jul 23;37(49):6285–6298. doi: 10.1038/s41388-018-0401-2

Fig. 6.

Fig. 6

In vivo CXCR4 antagonism greatly contrast atypical DP infiltration in N3-ICtg BM. Three- to four-week-old N3-ICtg mice were treated daily with PBS (PBS) or with the CXCR4 antagonist, AMD3100. At day10 post-injection, absolute numbers a of DP T-cells and b of Notch3+CXCR4+DP T-cells were analyzed. PBS, n = 3; AMD3100, n = 6. Results represent mean ± SD (*p < 0.05; **p < 0.01; Student’s t-test)